Skip to content

IV Dexamethasone in Preventing Post Spinal Hypotension

Efficacy of Dexamethasone in Preventing Postspinal Hypotension in Elderly Patients Undergoing Orthopedic Surgery: a Randomized Controlled Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07052864
Enrollment
134
Registered
2025-07-07
Start date
2025-06-30
Completion date
2025-08-05
Last updated
2025-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension During Surgery

Brief summary

Orthopedic lower limb procedures are carried out under spinal anesthesia which involves administration of drugs in the space surrounding the spinal cord. From there the drug acts on the spinal cord blocking electrical signals moving across nerve fibers thereby providing sufficient pain relief and surgical conditions. However blocking of these fibers result in reduce signal transmission to blood vessels and heart resulting in fall in blood pressure. Various drugs can be used to treat or prevent this hypotension. One such drug is Dexamethasone which is a steroid. This drug can be administered before spinal anesthesia through Intravenous route to prevent fall in blood pressure.

Detailed description

Lower limb orthopedic surgeries are carried out under Sub Arachnoid block which is associated with sympathectomy resulting in vasodilation and hypotension. The hypotension can compromise end organ perfusion and pre-disposes the person to end organ damage such as Myocardial infarction, stroke and renal injury. Therefore treatment and prevention of post spinal hypotension is one of the major goals to improve peri-operative outcomes. One such drug which can be used to prevent post spinal hypotension is Dexamethasone which can be given prophylactically to prevent post spinal hypotension as the drug causes increase in systemic vascular resistance thereby counteracting post spinal vasodilation and hypotension.

Interventions

DRUGDexamethasone

8 mg of Intravenous Dexamethasone in 100 ml Normal saline given 1 hour before anesthesia induction

DRUGPlacebo

100ml of Normal saline administration 1 hour before anesthesia induction

Sponsors

Pakistan Institute of Medical Sciences
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

After taking informed consent participants will be divided into two equal groups using computer generated random numbers. The participants in group D will receive 8 mg of IV Dexamethasone in 100ml Normal saline 1 hour before induction of spinal anesthesia while participants in group C will receive 100ml of Normal saline 1 hour before induction of spinal anesthesia. 1 hour after administration of IV Dexamethasone or placebo patient will be brought into OR, ASA monitoring will be attached, Sub Arachnoid block will be induced with 15mg of hyperbaric bupivacaine, patient will be made to lie down, level of block will be assessed and surgery will be started. Intraoperatively hemodynamics will be recorded at 5 minutes interval for first 30 minutes. Any fall in blood pressure by more than 20% from baseline will be noted and treated with Phenylephrine IV bolus.

Eligibility

Sex/Gender
ALL
Age
50 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing orthopedic surgery under spinal anaesthesia. * ASA I & II.

Exclusion criteria

* Known case of ischemic heart disease. * Patients having contraindication to spinal anesthesia (e.g.- coagulopathy, thrombocytopenia, allergy to local anesthetic agent). * Patients using corticosteroids or drugs that affect serotonin (e.g., selective serotonin reuptake inhibitor). * Patients with uncorrected hypovolemia.

Design outcomes

Primary

MeasureTime frameDescription
Systolic Blood Pressurebaseline, 5 mins, 10 mins, 15 mins, 20 mins, 25 mins,30 minsThis is the highest blood pressure during cardiac cycle occurring at the peak of systole measured by Non invasive automated blood pressure cuff
Diastolic Blood Pressurebaseline, 5 mins, 10 mins, 15 mins, 20 mins, 25 mins,30 minsThis is the lowest blood pressure during cardiac cycle measured by Non invasive automated blood pressure cuff
Mean Blood Pressurebaseline, 5 mins, 10 mins, 15 mins, 20 mins, 25 mins,30 minsThis is the average blood pressure during cardiac cycle measured by Non invasive automated blood pressure cuff

Secondary

MeasureTime frameDescription
Number of Hypotensive episodesIntraoperative periodThis will be the number of times in the intraoperative period the patient experience fall in either systolic, diastolic or mean blood pressure by more than 20% from baseline
Rescue PhenylephrineIntraoperative periodThis will be the total amount of phenylephrine administered in intraoperative period to the patient in case of fall in either systolic, diastolic or mean blood pressure by more than 20% from baseline
Rescue intravenous fluidIntraoperative periodThis will be the total amount of IV crystalloid fluid administered in intraoperative period to the patient in case of fall in either systolic, diastolic or mean blood pressure by more than 20% from baseline

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026